The ideal adjunct therapy would, therefore, reduce insulin dose requirement, lower HbA1c without increasing the risk of hypoglycaemia, reduce weight, and have direct effects to reduce the risk of cardiovascular disease and improve life expectancy [6, 7]. Here, INS is linked to Hypoglycemia.